Bora Pharmaceuticals completes acquisition of Emergent Biosolutions Maryland facility
Acquiring Company
Bora Pharmaceuticals Ltd
Acquired Company
Emergent Biosolutions
Taipei
GaithersburgManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyHealth CareDescription
Bora Pharmaceuticals, a Taiwan-based pharmaceutical company, has acquired Emergent Biosolutions' sterile manufacturing facility in Camden, Maryland, as part of its expansion strategy in the U.S. The acquisition will enable Bora to enhance its presence in North America and expand its capabilities in sterile drug product manufacturing.
Other recent acquisitions in Pharmaceutical and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Sudeep Pharma promoters regain 100% ownership by acquiring 50% shares from JRS Pharma (July 8, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- Edwards Lifesciences Completes Acquisitions of JenaValve Technology and Endotronix (July 24, 2024)
- AA Medical completes acquisition of Surgical Product Solutions, forming strategic partnership (July 11, 2024)
- Revelation Pharma expands with acquisitions of Taylors Pharmacy and Key Compounding (July 9, 2024)
Who to call at Bora Pharmaceuticals Ltd, and when
When Bora Pharmaceuticals Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Bora Pharmaceuticals Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bora Pharmaceuticals Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bora Pharmaceuticals Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bora Pharmaceuticals Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Emergent Biosolutions?
Emergent Biosolutions was acquired by Bora Pharmaceuticals Ltd, based in Taipei. The deal was reported on June 26, 2024. Bora Pharmaceuticals Co., Ltd. is a multinational pharmaceutical company that focuses on expanding its rare disease portfolio through strategic acquisitions. Bora Pharmaceuticals Ltd is publicly traded (BORAY) and operates in Manufacturing.
When did Bora Pharmaceuticals Ltd acquire Emergent Biosolutions?
Bora Pharmaceuticals Ltd's acquisition of Emergent Biosolutions was reported on June 26, 2024. Bora Pharmaceuticals, a Taiwan-based pharmaceutical company, has acquired Emergent Biosolutions' sterile manufacturing facility in Camden, Maryland, as part of its expansion strategy in the U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Emergent Biosolutions do?
Emergent Biosolutions is a Maryland-based pharmaceutical company that has sold its sterile manufacturing facility in Camden, Maryland, as part of its restructuring operations. It is publicly traded (EBS), operating in Manufacturing, and is based in Gaithersburg.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.